Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2021

View Archived Issues

New phase II/III study evaluates BLU-263 in patients with indolent systemic mastocytosis

Mechanism identified for HBsAg reduction with Aligos Therapeutics STOPS molecule ALG-10000

Newly identified lncRNA could be a biomarker of liver and pancreatic cancers

Morehouse School of Medicine Chlamydia vaccine VCG-Pmp18.3 is protective in vivo

Positive phase I data for AKS-452, a protein subunit COVID-19 vaccine candidate

Crinetics Pharmaceuticals synthesizes melanocortin MC2 receptor antagonists

Landos Biopharma patents new LANCL2 activators

U.S. Department of Health & Human Services divulges compounds for HIV infection

Janssen Pharmaceutica discloses new OGA inhibitors

Genentech patents anti-LY6G6D antibodies for colorectal cancer

Evaxion presents phase I/IIa data for its cancer immunotherapy candidates, EVX-01 and EVX-02

Study casts further light on cancer immunotherapy

Discovery, optimization and in vivo evaluation of novel tetrahydropyran-based galectin-3 inhibitors

Results of two trials of chemoattenuated PfSPZ vaccines in controlled human malaria infections

EDP-721, a novel HBV RNA destabilizer with promising preclinical efficacy

HDAC6 inhibitors improve LVEF in murine model of DCM

YH-34160 leads to potent and sustained body weight loss in DIO mouse model

Bioasis reports outcome of preclinical study of xB3-IL-1RA for MS

FDA clears eIND for 68Ga-RMX-VH in glioblastoma multiforme

Biomarker panel identifies cardiovascular risk and benefit from SGLT2 inhibitors

Novel SARS-CoV-2 inactivated vaccine induces robust immune responses in healthy adults

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.